1. Home
  2. EVO vs AWF Comparison

EVO vs AWF Comparison

Compare EVO & AWF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$1.82

Market Cap

778.3M

Sector

Health Care

ML Signal

HOLD

Logo Alliancebernstein Global High Income Fund

AWF

Alliancebernstein Global High Income Fund

HOLD

Current Price

$10.04

Market Cap

868.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVO
AWF
Founded
1993
1993
Country
Germany
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
778.3M
868.3M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
EVO
AWF
Price
$1.82
$10.04
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
41.4K
254.4K
Earning Date
04-08-2026
01-01-0001
Dividend Yield
N/A
7.57%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1.37
N/A
Revenue Next Year
$10.05
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.80
$9.85
52 Week High
$4.27
$11.43

Technical Indicators

Market Signals
Indicator
EVO
AWF
Relative Strength Index (RSI) 39.03 40.47
Support Level N/A $9.98
Resistance Level $1.97 $10.23
Average True Range (ATR) 0.03 0.04
MACD 0.00 -0.01
Stochastic Oscillator 17.65 8.57

Price Performance

Historical Comparison
EVO
AWF

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

About AWF Alliancebernstein Global High Income Fund

Alliancebernstein Glb High Inc Fund Inc is a United States-based diversified, closed-end management investment company. Its primary investment objective is to seek high current income, and secondarily, capital appreciation. The fund invests in debt securities, including Sovereign Debt Obligations and corporate debt, denominated in non-U.S. currencies as well as in the U.S. Dollar. It may invest without limit in emerging and developed markets and debt securities of U.S. and non-U.S. corporate issuers.

Share on Social Networks: